Effects of Combined Natural Molecules on Metabolic Syndrome in Menopausal Women
NCT ID: NCT06057896
Last Updated: 2023-11-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
200 participants
OBSERVATIONAL
2022-09-30
2023-08-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Cocoa Polyphenols Supplementation on Cardiovascular Risk of Postmenopausal Women
NCT05158673
4-week Seaweed Supplementation on Menopause Symptoms and Psychological Wellbeing
NCT05759936
Polyphenol Metabolism and Personalized Nutrition in Menopause (PolyPause).
NCT07182370
Polyphenols and Probiotics to Improve Menopausal Symptoms Via the Gut-Brain Axis
NCT06333223
Randomized Placebo Controlled Clinical Study of an Oral Product in Subjects With Menopausal Symptoms
NCT06787443
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
inositol, phytoestrogens, cocoa polyphenols
inositol, phytoestrogens, cocoa polyphenols
myo-inositol, soy isoflavones and cocoa polyphenols
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
inositol, phytoestrogens, cocoa polyphenols
myo-inositol, soy isoflavones and cocoa polyphenols
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* diagnosis of metabolic syndrome
Exclusion Criteria
* hormonal therapies
* sensitizing insulin therapies
* cancer patient or ex-cancer patient
45 Years
60 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lo.Li.Pharma s.r.l
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mario Passaro, MD
Role: PRINCIPAL_INVESTIGATOR
ASL NA3 Sud, Naples, Italy.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
SCCAL
Naples, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Ins-SM-23
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.